Cancer mortality and senescence: Is redox therapy an option?
Shan Kuang1, Manojit M Swamynathan1, Lloyd C Trotman2
1Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA.
Genes & Development
|July 14, 2025
Summary
Senescence acts as a barrier to prostate cancer metastasis. Exploring the redox state of senescent cells may reveal new markers and vulnerabilities for cancer therapy.
Area of Science:
- Oncology
- Cell Biology
- Genetics
Background:
- Senescence is a known barrier to metastatic progression in prostate cancer.
- Current research focuses on eliminating senescent cells or understanding their unique characteristics.
- Distinct cellular features differentiating senescent from normal or aging cells require further elucidation.
Purpose of the Study:
- To explore the redox state of senescent cells in prostate cancer.
- To identify potential new biomarkers for senescent cells.
- To uncover pro-oxidant vulnerabilities in senescent cancer cells.
Main Methods:
- Review of patient genomics data.
- Analysis of mouse functional genetics studies.
- Comparative analysis of senescent versus normal and aging cells.
- Exploration of redox biology principles.
Main Results:
- Senescence functions as a critical barrier against prostate cancer metastasis.
- The redox state of senescent cells presents a promising area for investigation.
- Potential for identifying novel senescent cell markers and therapeutic targets.
Conclusions:
- Understanding the redox state of senescent cells is key to defining new markers.
- Pro-oxidant vulnerabilities in senescent cells could be therapeutically exploited.
- This approach parallels known redox sensitivities in proliferating cancer cells.
More Related Videos
08:56Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
Published on: July 12, 2022
3.1K
14:01Far-Red Fluorescent Senescence-Associated β-Galactosidase Probe for Identification and Enrichment of Senescent Tumor Cells by Flow Cytometry
Published on: September 13, 2022
4.9K
Related Concept Videos
01:46Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
02:15Replicative Cell Senescence
3.7K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
02:53Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:37Mitochondria
15.1K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
15.1K